A. Haack

Haemophilia A: Mutation Type Determines Risk of Inhibitor Formation

J. Oldenburg, R. Schwaab, E. Tuddenham, 1995, Thrombosis and Haemostasis.

Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines

J. Oldenburg, W. Poller, R. Schwaab, 1999, Annals of Hematology.

Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

A. Houtsmuller, H. Fechner, X. Wang, 1999, Gene Therapy.

Molecular characterisation of the defective α1-antitrypsin alleles PI Mwürzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68lle)

H. Fechner, A. Haack, W. Poller, 1999, European Journal of Human Genetics.

Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.

U. Liebert, W. Poller, R. Schwaab, 1996, Gene therapy.

‘Autoreplication’ of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes

W. Poller, A. Haack, H. Brackmann, 1999, Gene Therapy.